LANSING - The percentage of adults without health insurance in Michigan has increased slightly, but remains below the national average, a report issued by the Department of Community Health said. However, the report also showed that the number of uninsured children in Michigan fell and is far lower than the national average. The report reviewed
LANSING - The state could have two, rather than one, proton beam therapy facility under regulations being considered by the Certificate of Need Commission. But the new rules would make it easier to develop a collaborative to run the facility and would allow the rules to cover more technology. The commission will be taking two
LANSING - Neogen Corporation on Tuesday announced its revenues surpassed $100 million for the first time, while fiscal 2008 earnings set a new high as well. Neogen, which develops and markets products dedicated to food and animal safety, reported a 19 percent increase in revenues for its 2008 fiscal year, which ended May 31, and
ANN ARBOR - William Brinkerhoff has joined the Board of Directors at Velcura Therapeutics. Brinkerhoff was vice president of business development for Esperion Therapeutics in Ann Arbor, where he successfully negotiated multiple large potential partnering agreements prior to Esperion's acquisition by Pfizer for $1.3 billion. Velcura just completed a first-in-man clinical trial for VEL-0230, an
ANN ARBOR - The University of Michigan Health System has been named to the list of the nation�??s 100 Most Wired and Most Wireless hospitals, says a new survey released this week. The study, in the July issue of Hospitals & Health Networks magazine, focuses on how the nation's hospitals use information technology for quality,
ALLEGAN - Perrigo Company, the world's largest manufacturer of over-the-counter healthcare products sold under the store-brand label, announced Tuesday it will invest $10.5 million to expand its facilities at its world headquarters in Allegan, adding 400 jobs during the next five years. The expansion is aided by tax credits approved today by the State of
LANSING - A group hoping to amend the Michigan Constitution to allow embryonic stem cell research in the state provided itself a substantial buffer in filing 570,016 signatures toward a spot on the November ballot. That filing launched the voter campaigns for both sides, as opponents did not expect to be able to disqualify enough
ANN ARBOR - Biopharmaceutical company NanoBio Corp has appointed announced Daniel B. Dubin, M.D., to its board of directors. Dr. Dubin currently serves as Vice Chairman and a Director at Leerink Swann, a leading healthcare and biotechnology investment banking firm. "Dr. Dan�'s keen understanding of the life sciences investment banking field and his clinical experience
LANSING - Under federal objections, certificate of need rules that required a proton beam therapy facility in the state to operate under a cooperative of hospitals were struck down. But the idea of a cooperative came back in the initial approval of a facility for Beaumont Hospitals. The Certificate of Need office granted initial approval
ANN ARBOR - NanoBio Corp. has been named to the annual FierceBiotech Fierce 15 list, designating the University of Michigan spin off as one of the top biotechnology companies in the country. NanoBio has developed a rich pipeline of anti-infective lotions and vaccines to combat a diverse range of bacteria, viruses and fungi, from MRSA